Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1624 1625
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18476916 | METHODS OF TREATING HIDRADENITIS SUPPURATIVA | Non-Final OA | AbbVie Inc. |
| 18277748 | UNSYMMETRIC LINEAR CARBONATE AND METHOD FOR PREPARING THEREOF | Final Rejection | LG CHEM, LTD. |
| 18720202 | BCL6 DEGRADERS AND USES THEREOF | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17759817 | USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS | Non-Final OA | Board of Regents, The University of Texas System |
| 18256645 | SUBSTITUTED PYRAZOLYL PIPERIDINE CARBOXYLIC ACIDS | Final Rejection | BAYER AKTIENGESELLSCHAFT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy